Press release
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tech Insights
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others. They encompass a wide range of products such as vaccines, monoclonal antibodies, and gene therapies, which are often used to treat complex diseases like cancer and autoimmune disorders. Unlike traditional drugs, which are chemically synthesized, biologics are typically large, complex molecules that cannot be easily characterized. Their production involves biological processes and requires stringent quality control to ensure consistency and efficacy across batches. As advanced therapeutics, biologics represent a significant area of innovation in modern medicine.
Explore market trends, size, share and growth report - request a sample copy: https://meditechinsights.com/biologics-market/request-sample/
Rising prevalence of chronic diseases to propel market demand
The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, is significantly driving the biologics market. Biologics, including monoclonal antibodies, vaccines, and gene therapies, offer targeted, effective treatments for these complex conditions. As chronic diseases continue to increase globally due to aging populations and lifestyle factors, the demand for advanced therapies like biologics has surged. Biologics provide enhanced efficacy, reduced side effects, and personalized treatment options, making them critical in addressing the growing burden of chronic diseases. This trend is pushing pharmaceutical companies to invest heavily in biologic drug development and innovation.
Growing investment in biopharmaceutical R&D driving the market growth
Growing investment in biopharmaceutical R&D is a key driver of the biologics market. Pharmaceutical companies are increasingly allocating resources to develop innovative biologic therapies, recognizing their potential to treat complex diseases effectively. This surge in investment supports advancements in biotechnology, leading to the discovery of novel biologics, including monoclonal antibodies and cell therapies. Additionally, collaborations between academia, industry, and government institutions foster a conducive environment for R&D, accelerating the pipeline of biologic products. As a result, the increased focus on biopharmaceutical R&D is propelling market growth by expanding treatment options and enhancing patient outcomes.
Explore the latest trends and deep insights, Get Report: https://meditechinsights.com/biologics-market/
Competitive Landscape Analysis
The global biologics market is marked by the presence of established and emerging market players such as AbbVie Inc., Amgen Inc., Biogen, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Roche Holding AG, Samsung BioLogics and Sanofi; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Latest Healthcare & Pharma Industry Research Reports
Transplantation Market: https://meditechinsights.com/transplantation-market/
Proteomics Market: https://meditechinsights.com/proteomics-market/
Cardiac Resuscitation Devices Market: https://meditechinsights.com/cardiac-resuscitation-devices-market/
Contact:
Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tech Insights here
News-ID: 4013225 • Views: …
More Releases from Medi-Tech Insights
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
Global Dental Equipment Market to Grow at 5-6% Annually by 2029; Top Key Players …
The global dental equipment market is set to witness a growth rate of 5-6% in the next 5 years. Aging population especially in developed regions, growing adoption of digital dentistry, increasing demand for aesthetic & preventative dental care, technological advancements, and rising dental awareness, medical tourism & accessibility in emerging markets are some of the key factors driving the dental equipment market.
Dental equipment includes tools and devices used by dental…
More Releases for Biologics
Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top C …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad
DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by…
Platinum Biologics Highlights Rising Consumer Confusion in the Biologics Market
[Orlando, USA - March 27, 2026] - A growing wave of consumer uncertainty is reshaping how patients and buyers approach the biologics market, particularly in emerging categories such as exosomes. As interest accelerates, so does confusion-driven by inconsistent standards, complex terminology, and a flood of marketing claims that are difficult for non-experts to verify.
Recent observations shared by Platinum Biologics point to a clear behavioral shift: consumers are no longer relying…
Biologics CDMO Services Market is Booming Worldwide | Lonza Group, Catalent, Sam …
The latest study released on the Global Biologics CDMO Services Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Biologics CDMO Services study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Major…
Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
